In recent years, in addition to the research targeting PD-1/PD-L1 checkpoint alone, researchers have found that depletion of PD-1+ T lymphocytes also significantly improved the progression of autoimmune diseases. The gene discussed is PDCD1; the disease is autoimmune disease.